FDA 483 - SC Johnson Professional USA, Inc. - October 30, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspected Deb USA Inc. in Stanley, NC, a drug manufacturer, from October 22-30, 2018, and issued nine observations. The inspection revealed significant deficiencies in quality control, laboratory practices, and equipment design, particularly concerning microbiological testing, data integrity, and water systems. Several issues were repeat observations from previous inspections, indicating systemic failures to ensure product quality and compliance with established procedures and regulations.
ID · 4d42c68b-5a21-4bc6-b23a-c3556c37b9b9